Control of Pain in Intravitreal Injections: Evaluation of Combination Topical Anesthetics and Non-steroidal Anti-inflammatory Drops: A Randomized, Placebo-Controlled Clinical Trial

Ophthalmol Retina. 2021 Mar;5(3):308-309. doi: 10.1016/j.oret.2020.08.015. Epub 2020 Aug 25.

Authors

Maxwell J Wingelaar¹, C Rufus Sweeney², Christina Thomas-Virnig³, Joseph J Raevis³, Jonathan S Chang³, Mihai Mititelu³

Affiliations

¹ Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin. Electronic address: mwingelaar@uwhealth.org.
² School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
³ Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin.

PMID: 32858247
DOI: 10.1016/j.oret.2020.08.015

No abstract available

Keywords: Anti–vascular endothelial growth factor; Intravitreal injection; Nonsteroidal anti-inflammatory drugs; Pain; Proparacaine.

Publication types

Randomized Controlled Trial

MeSH terms

Anesthetics, Local / administration & dosage*
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Double-Blind Method
Drug Therapy, Combination
Eye Pain / drug therapy*
Eye Pain / etiology
Humans
Intravitreal Injections / adverse effects
Ophthalmic Solutions
Pain Management / methods*
Pain Measurement
Retrospective Studies

Substances

Anesthetics, Local
Anti-Inflammatory Agents, Non-Steroidal
Ophthalmic Solutions